
结论很明确:这个市场不值得进入,已经是高竞争、低利润、接近价格战的赛道。 新品牌只有7.69%成功,12个新产品里有92.31%失败;更关键的是,当前看不到30个以上新品牌的扩张浪潮,但胜出的样本几乎只集中在少数老品牌,说明不是蓝海,而是成熟品牌在卡位,普通新进入者很难跑出来。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这个市场不值得进,500000元预算足够启动,但不足以支撑长期竞争;现在更像价格战+低成功率市场。 用户预算远高于单个新产品的建议起步资金约14,532.93美元(约10.5万人民币上下),所以“能不能开局”是YES;但市场里新品牌新上架的盈利率只有0%,整体可识别盈利产品占比也只有9.09%,最近新增里连续出现多款亏损新品,说明不是好做,而是难做。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经接近价格战区,且新品牌成功率极低。 关键证据很直接:新上市产品里只有7.69%能盈利,92.31%失败;新品牌里已经能看到 Veco、JUSUFU、Emarful、Dunkive、Topupth、YUIECHER、SANLIKE 等多家新入局者集中失败,属于明显的拥挤市场,不是适合新手或大品牌轻松切入的赛道。
从大品牌看,FLAIROSOL 是唯一能拿得出手的标杆,但它也不是“低成本复制型”机会:成功 ASIN B0FC66DXZT 的投入约 14,532.93 美元,月销 100 件、月营收 2,299 美元、利润率才 22.99%,而品牌里还有 2 个失败品,说明这不是“随便上个同类款就能赢”的市场。它能赢,靠的是更高颜值、更强细雾体验、密封防漏、700ml 大容量的组合;但你要注意,另一款新上架但失败的 B0FQ4ZQ9FD 直接证明了同品牌内也会翻车,说明这里对产品力和定位要求很高。
小商家角度更不乐观。 真正可参考的小商家成功案例几乎没有;相反,像 Veco 的 B0GLMXXG9F 只卖 $9.29,刚上架就只有 4 个评价、-16.62% 利润率、且是非活跃销售,这种结果说明低价入口已经被成本结构压死。再看老品牌 MyLifeUNIT 的 B07BWBFDHZ,虽然月销 1000 件、月营收 18,840 美元,但利润率只有 -4.32%,2154 条评价也明显属于成熟大牌盘踞,不是小商家榜样。结论很明确:大品牌可以靠重投入和差异化勉强打,但小商家不应进入;若没有明显创新、品牌力和更高预算,进去大概率就是亏损。
这个市场不值得进入,已经明显进入过度拥挤甚至价格战区。 新品利润分布里,已知利润产品只有 7.69% 落在 20%~30%,而新品牌新上架产品的盈利率直接是 0%,近一年的新品几乎都在亏或没跑出来;同时今年 2026 年又冒出 Veco、Emarful、YUIECHER、SANLIKE、Dunkive、JUSUFU、Topupth 等新品牌,但没有一个新品牌做出可验证的盈利结果,说明不是“还有空位”,而是“新品牌进来就被打掉”。
证据很清楚:低利润和失败样本占绝对多数。 全市场可识别利润样本里,38.64% 是亏损低于 -10%,再加上 6.82% 处于 0%~10%,意味着大量产品落在低毛利甚至亏损区;按规则,利润率低于 10% 本身就是高风险,而当前新产品里只有 1 个样本勉强到 20%~30%(FLAIROSOL 的 B0FC66DXZT,月销 100,月营收约 $2,299,近期月利润约 $612,单品预算约 $14,532.93),其余像 Veco 的 B0GLMXXG9F($9.29,-16.62%)和 JUSUFU 的 B0FN3YJTG6($13.72,未形成销量)都没跑通。真正能赚钱的少数案例几乎都来自老品牌:FLAIROSOL 的 B0FC66DXZT、B0B6DZSBT2,以及 EXTREMEMIST 的 B0BR8HQ5NC、B0BQZCCCLD;而失败案例大多是通用款、外观和功能都太像,Calvalor、OFFIDIX、MyLifeUNIT 这类产品都在低价通用结构里被压到负利润。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FC66DXZT | FLAIROSOL | 2025-09-07 | Yes | $22.99 | 100pcs | $2299.0 | 26.63% | $612.23 |
![]() | B0BR8HQ5NC | EXTREMEMIST | 2023-01-05 | Yes | $29.95 | 50pcs | $1497.5 | 24.27% | $363.45 |
![]() | B0BQZCCCLD | EXTREMEMIST | 2023-01-28 | Yes | $24.95 | 50pcs | $1247.5 | 19.88% | $248.01 |
![]() | B0B6DZSBT2 | FLAIROSOL | 2022-07-12 | Yes | $14.74 | 50pcs | $737.0 | 18.91% | $139.37 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FC66DXZT | FLAIROSOL | 2025-09-07 | Yes | $22.99 | 100pcs | $2299.0 | 26.63% | $612.23 |
这个市场不值得进入,已经明显走向低利润高竞争。 新品牌几乎没有真正的成功样本,新品牌新上架产品成功率只有7.69%,而新品牌样本里是100%失败;整体可识别盈利产品只有9.09%,这已经接近高风险区。市场里真正能赚钱的,基本都来自老牌玩家或依托老爆款改良,说明新进入者面对的是成熟品牌壁垒,而不是蓝海机会。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,属于明显的高风险价格战市场:新品牌几乎没有成功,最近新增基本都在失败,盈利只集中在极少数老品牌的少数款上,说明不是普通卖家能靠常规铺货切进去的。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 7 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| 2025/9 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |